An overview of the amount of benchmark reports throughout review stage and analyze indication for resp. IBD and MM.Contributors had been purposively sampled to guarantee representation of all four countries and different forms of pharmaceutical organizations and CROs with regard to dimension and therapeutic region of expertise. The participants sho